A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma
NCT05481437
·
clinicaltrials.gov ↗
RECRUITING
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Hodgkin Lymphoma
Interventions
DRUG:
Brentuximab Vedotin
Sponsor
Takeda